Platelet transfusion therapy in newborn infants.
暂无分享,去创建一个
V. Blanchette | J. Hellmann | T. Kühne | H. Hume | H. Hume
[1] N. Luban. Massive transfusion in the neonate. , 1995, Transfusion medicine reviews.
[2] S. Frøland,et al. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. , 1994, The New England journal of medicine.
[3] V. Blanchette,et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura , 1994, The Lancet.
[4] A. Brand. Passenger leukocytes, cytokines, and transfusion reactions. , 1994, The New England journal of medicine.
[5] J. Kelton,et al. The role of the plasma from platelet concentrates in transfusion reactions. , 1994, The New England journal of medicine.
[6] P. Newman. Nomenclature of human platelet alloantigens: a problem with the HPA system? , 1994, Blood.
[7] A. E. Horvath,et al. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. , 1994, JAMA.
[8] M. Gent,et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. , 1993, The Journal of pediatrics.
[9] A. Jefferies,et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. , 1993, The Journal of pediatrics.
[10] M. Morel-Kopp,et al. Neonatal thrombocytopenia and hidden maternal autoimmunity , 1993, British journal of haematology.
[11] K. Nicolaides,et al. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. , 1993, Blood.
[12] R. Strauss. Selection of white cell‐reduced blood components for transfusions during early infancy , 1993, Transfusion.
[13] E. Beutler. Platelet transfusions: the 20,000/microL trigger [see comments] , 1993 .
[14] M. Albanese,et al. National survey of neonatal transfusion practices: II. Blood component therapy. , 1993, Pediatrics.
[15] R. Strauss,et al. National acceptability of American Association of Blood Banks Pediatric Hemotherapy Committee guidelines for auditing pediatric transfusion practices , 1993, Transfusion.
[16] K. McCrae,et al. Pregnancy-associated thrombocytopenia: pathogenesis and management. , 1992, Blood.
[17] D. Triulzi,et al. Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis , 1992, Transfusion.
[18] J. Fehr,et al. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia , 1991, The Lancet.
[19] R. Strauss,et al. Transfusion therapy in neonates. , 1991, American journal of diseases of children.
[20] R. Strauss,et al. Guidelines for auditing pediatric blood transfusion practices. , 1991, American journal of diseases of children.
[21] T. Yeh,et al. The effect of low-dose dopamine infusion on cardiopulmonary and renal status in premature newborns with respiratory distress syndrome. , 1991, American journal of diseases of children.
[22] M. Morel-Kopp,et al. HPA‐5b (Bra) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases , 1991, British journal of haematology.
[23] S. E. Lind,et al. The bleeding time does not predict surgical bleeding (see comments) , 1991 .
[24] R. Hillman,et al. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion , 1991, Transfusion.
[25] D. Roos,et al. In vitro Evaluation of Buffy‐Coat‐Derived Platelet Concentrates Stored in a Synthetic Medium 1 , 1991, Vox sanguinis.
[26] B. Paes,et al. Evaluation of an automated bleeding time device in the newborn , 1990, American journal of hematology.
[27] N. Luban,et al. Blood component therapy in the perinatal period: guidelines and recommendations. , 1990, Seminars in perinatology.
[28] L. Braitman,et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura , 1990, The New England journal of medicine.
[29] Francine Décary,et al. ICSH/ISBT Working Party on Platelet Serology , 1990 .
[30] V. Blanchette,et al. Alloimmunization to the PIA1 platelet antigen: results of a prospective study , 1990, British journal of haematology.
[31] L. Mitchell,et al. Modified bleeding time in the infant , 1989, American journal of hematology.
[32] G. Mueller‐Eckhardt,et al. 348 CASES OF SUSPECTED NEONATAL ALLOIMMUNE THROMBOCYTOPENIA , 1989, The Lancet.
[33] M. Contreras,et al. Maternal alloimmunization to HLA, platelet and granulocyte‐specific antigens during pregnancy: its influence on cord blood granulocyte and platelet counts , 1989, British journal of haematology.
[34] C J Carter,et al. Reduced platelet count as a risk factor for intraventricular hemorrhage. , 1988, American journal of diseases of children.
[35] H. Kiyokawa,et al. Prevention of acquired defects in platelet function during blood processing , 1988, Transfusion.
[36] Boscoe M. Paes,et al. Development of the human coagulation system in the healthy premature infant. , 1988, Blood.
[37] V. Blanchette,et al. High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. , 1988, The Journal of pediatrics.
[38] R. Heinz,et al. Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates , 1988, Transfusion.
[39] H. Braine,et al. The utility of platelet washing using an automated procedure for severe platelet allergic reactions , 1987, Transfusion.
[40] P. Powers,et al. Development of the human coagulation system in the full-term infant. , 1987, Blood.
[41] P. Carey,et al. Frozen maternal platelets for neonatal thrombocytopenia , 1987, Transfusion.
[42] W. Zinkham,et al. Kasabach-Merritt syndrome: therapeutic considerations. , 1987, Pediatrics.
[43] J. Kelton,et al. Clinical impact of neonatal thrombocytopenia. , 1987, The Journal of pediatrics.
[44] R. Aster,et al. Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion. , 1986, Annals of internal medicine.
[45] J. Kelton,et al. Frequency and mechanism of neonatal thrombocytopenia. , 1986, The Journal of pediatrics.
[46] V. Blanchette,et al. Treatment of acute idiopathic thrombocytopenic purpura. , 1986, The Journal of pediatrics.
[47] N. Luban,et al. Reduction of the volume of stored platelet concentrates for use in neonatal patients , 1984, Transfusion.
[48] T. Simon,et al. Concentration of platelet units into small volumes , 1984, Transfusion.
[49] J. Kelton. Management of the Pregnant Patient with Idiopathic Thrombocytopenic Purpura , 1983 .
[50] Gill Fm. Thrombocytopenia in the newborn. , 1983 .
[51] P. Powers,et al. The prenatal prediction of thrombocytopenia in infants of mothers with clinically diagnosed immune thrombocytopenia. , 1982, American journal of obstetrics and gynecology.
[52] M. Mennuti,et al. Immune thrombocytopenic purpura and pregnancy. , 1982, The New England journal of medicine.
[53] S. Karpatkin,et al. Platelet counts in infants of women with autoimmune thrombocytopenia: effects of steroid administration to the mother. , 1982, The New England journal of medicine.
[54] T. Koerner,et al. Platelet Concentrates Influence of Different Preparative Protocols on the in vitro Release Reaction 1 , 1982, Vox sanguinis.
[55] S. Karpatkin,et al. Platelet Counts in Infants of Women with Autoimmune Thrombocytopenia , 1981 .
[56] C. Abildgaard,et al. Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. , 1981, Pediatrics.
[57] J. Cosgrove,et al. Isoimmune thrombocytopenia treated with random donor platelets. , 1981, Irish medical journal.
[58] R. Pitkin,et al. Fetal platelet counts in the obstetric management of immunologic thrombocytopenic purpura. , 1980, American journal of obstetrics and gynecology.
[59] Harker La,et al. Thrombocytopenia: mechanisms and management of defects in platelet production. , 1978, Clinics in haematology.
[60] J. Hutter,et al. Hematologic abnormalities in severe neonatal necrotizing enterocolitis. , 1976, The Journal of pediatrics.
[61] A. Zipursky,et al. The hematology of bacterial infections in premature infants. , 1976, Pediatrics.
[62] Leighton Da. Letter: Wound infection in acute appendicitis. , 1974, Lancet.
[63] H. Pearson,et al. Neonatal isoimmune purpura: response to platelet infusions. , 1973, The Journal of pediatrics.
[64] Chapman Gw. Neonatal blood disorders. , 1969 .
[65] M. Adner,et al. Use of "compatible" platelet transfusions in treatment of congenital isoimmune thrombocytopenic purpura. , 1969, The New England journal of medicine.
[66] V. Marder,et al. ISOIMMUNE NEONATAL THROMBOCYTOPENIC PURPURA. CLINICAL AND THERAPEUTIC CONSIDERATIONS. , 1964, Blood.
[67] N. Mantel,et al. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. , 1962, The New England journal of medicine.
[68] K. Merritt,et al. CAPILLARY HEMANGIOMA WITH EXTENSIVE PURPURA: REPORT OF A CASE , 1940 .
[69] A. Heaton,et al. Quality of platelet concentrates. , 1995, Immunological investigations.
[70] John C. Sinclair,et al. Effective care of the newborn infant , 1992 .
[71] Bowie Ej,et al. The bleeding time. , 1991, Lancet.
[72] R. Eisenstaedt. Blood component therapy in the treatment of platelet disorders. , 1986, Seminars in hematology.
[73] H. Mangurten,et al. Blood component transfusion in the intensive care nursery. Indications and special problems. , 1984, American Journal Of Pediatric Hematology/Oncology.
[74] G. Avery. Neonatology: Pathophysiology and management of the newborn , 1981 .
[75] A. Zipursky,et al. Clinical and laboratory diagnosis of hemostatic disorders in newborn infants. , 1979, The American journal of pediatric hematology/oncology.
[76] W. Appleyard,et al. Venous platelet counts in low birth weight infants. , 1971, Biology of the neonate.